Dr James Heward

Postdoctoral Researcher
Research Focus

My research within the Fitzgibbon lab focuses on characterising epigenetic therapies for the “epigenetically addicted” germinal centre lymphomas, whilst my previous work has included working at an epigenetic focused BioTech company (Chroma Therapeutics Ltd) and characterising long non-coding RNAs that regulate the innate immune response during my PhD (University of Bath).

Professor Jude Fitzgibbon